Downregulation of xIAP Expression by Small Interfering RNA Inhibits Cellular Viability and Increases Chemosensitivity to Methotrexate in Human Hepatoma Cell Line HepG2-Reference-Cited by-同舟云学术

Downregulation of xIAP Expression by Small Interfering RNA Inhibits Cellular Viability and Increases Chemosensitivity to Methotrexate in Human Hepatoma Cell Line HepG2

Published:2006-10 Issue:5 Volume:18 Page:525-531
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Chen Jun,Xiao Xin-Qiang,Deng Chun-Ming,Su Xian-Shi,Li Gui-Yuan

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference28 articles.

1. Hepatocellular carcinoma

2. Yu-Chih Liang, Chih-Hsiung Wu, Jan-Show Chu, et al. Involvement of fatty acid-CoA ligase 4 in hepatocellular carci-noma growth: Roles of cyclic AMP and p38 mitogen-activated protein kinase World J Gastroenterol 2005; 11 (17): 2557-63.

3. Burstein E, Ganesh L, Dick RD, et al. A novel role for XIAP in copper homeostasis through regulation of MURR1, EMBO J 2004; 23 (1): 244-54.

4. Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methotrexate induced cell death mechanisms in MCF-7 adenocarcinoma breast cancer cells: Enhanced cytotoxicity following dff45-siRNA pre-treatment;Synergy;2018-12

2. The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma;Frontiers in Pharmacology;2018-11-06

3. Inhibitor of apoptosis protein‑like protein‑2: A novel growth accelerator for breast cancer cells;Oncology Reports;2018-08-03

4. Inhibition of X-linked inhibitor of apoptosis protein suppresses tumorigenesis and enhances chemosensitivity in anaplastic thyroid carcinoma;Oncotarget;2017-09-28

5. HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP;Biomedicine & Pharmacotherapy;2015-03